Cost–effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain

References

• Holmes C , Foley P , Freeman M , Chong AH . Solar keratosis: epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol 2007;48:67-74
   PubMed Web of Science ®Google Scholar
• de Berker D , McGregor JM , Hughes BR ; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee . Guidelines for the management of actinic keratoses. Br J Dermatol 2007;156:222-30. Erratum in: Br J Dermatol 2008;158:873
   PubMed Web of Science ®Google Scholar
• Bernard P , Dupuy A , Sasco A , et al. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey. Dermatology 2008;216:194-9
   PubMed Web of Science ®Google Scholar
• Massa A , Alves R , Amado J , et al. [Prevalence of cutaneous lesions in Freixo de Espada a Cinta]. Acta Med Port 2000;13:247-54
   PubMedGoogle Scholar
• Memon AA , Tomenson JA , Bothwell J , Friedmann PS . Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000;142:1154-9
   PubMed Web of Science ®Google Scholar
• Naldi L , Chatenoud L , Piccitto R , et al. Prevalence of actinic keratosis and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004. Arch Dermatol 2006;142:722-6
   PubMedGoogle Scholar
• Rigel DS , Stein Gold LF . The importance of early diagnosis and treatment of actinic keratosis. J Am Acad Dermatol 2013;68(Suppl 1):S20-7
   PubMed Web of Science ®Google Scholar
• Ferrándiz C , Fonseca-Capdevila E , García-Diez A , et al. Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis. Actas Dermosifiliogr 2014;105:378-93
   PubMedGoogle Scholar
• Berman B , Amini S . Pharmacotherapy of actinic keratosis: an update. Expert Opin Pharmacother 2012;13:1847-71
   PubMed Web of Science ®Google Scholar
• Fu W , Cockerell CJ . The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol 2003;139:66-70
   PubMed Web of Science ®Google Scholar
• General Spanish Council of Pharmacist. Madrid. Spain, 2014. Available from: www.portalfarma.com [Last accessed 1 March 2014]
   Google Scholar
• Dirschka T , Dominicus R , Lars K , et al. Long term efficacy and recurrence of topical 0.5% 5-fluorouracil with 10% salicylic acid for actinic keratosis compared to cryotherapy a prospective, active controlled, randomized, exploratory study [Poster]. In: 6th World Meeting of Interdisciplinary Melanoma/Skin Cancer Centres and 8th EADO Congress. Barcelona. Spain, 2012. Available from: www.eado.org/activities/eado-congress/8 [Last accessed 1 March 2014]
   Google Scholar
• Stockfleth E , Kerl H , Zwingers T , Willers C . Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol 2011;165:1101-8
   PubMed Web of Science ®Google Scholar
• Wilson EC . Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model. Pharmacoeconomics 2010;28:1055-64
   PubMed Web of Science ®Google Scholar
• Szeimies RM , Karrer S , Radakovic-Fijan S , et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002;47:258-62
   PubMed Web of Science ®Google Scholar
• Spanish Health Costs Database eSalud. Oblikue Consulting S.L. Barcelona. Spain, 2014. Available at www.oblikue.com [Last accessed 7 july 2014]
   Google Scholar
• Stockfleth E , Zwingers T , Willers C . Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol 2012;22:370-4
   PubMed Web of Science ®Google Scholar
• Krawtchenko N , Roewert-Huber J , Ulrich M , et al. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007;157(Suppl 2):34-40
   PubMed Web of Science ®Google Scholar
• Czarnecki D , Meehan CJ , Bruce F , Culjak G . The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg 2002;6:207-9
   PubMed Web of Science ®Google Scholar
• Criscione VD , Weinstock MA , Naylor MF , et al. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009;115:2523-30
   PubMed Web of Science ®Google Scholar
• Colombo GL , Chimenti S , Di Matteo S , et al. Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system. G Ital Dermatol Venereol 2010;145:573-81
   PubMed Web of Science ®Google Scholar
• Fluorouracil 0.5%/ salicylic acid 10% cutaneous solution (Actikerall®). SMC No. (728/11). Scottish Medicines Consortium (SMC). 2011. Available from: http://www.scottishmedicines.org.uk/files/advice/fluorouracil_and_salicylic_acid_Actikerall_FINAL_September_2011_for_website.pdf [Last accessed 1 March 2014]
   Google Scholar